" class="no-js "lang="en-US"> AmerisourceBergen Archives - Medtech Alert
Friday, April 12, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Patient Discovery Partners with AmerisourceBergen for Cancer Care Equity

Patient Discovery Solutions, a leader in health equity solutions that harness the power of patient-centered […]

AmerisourceBergen Launches Cell and Gene Therapy Innovation Hub

AmerisourceBergen, a global healthcare company, has announced the launch of its Cell and Gene Therapy […]

SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices

SamaCare, a prior authorization platform for physician-administered medications, today announced a partnership with AmerisourceBergen Specialty […]

AmerisourceBergen Kicks Off Strategic Relationship with Civica

Starting today, global healthcare company AmerisourceBergen will serve as an exclusive distribution partner and provide […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more